Valued at a market cap of $56.7 billion, Air Products and Chemicals, Inc. (APD) is a global leader in industrial gases and ...
For over a decade, and as recently as August, FDA has fully evaluated the emerging scientific evidence and repeatedly ...
Kenvue stock is down 28% in 2025 amid controversy surrounding its Tylenol brand, which is linked to autism when used during ...
Bessent calls $20 billion lifeline to Argentina a ‘mission-critical’ function of Treasury during shutdown ...
In today’s Pharmaceutical Executive Daily, we cover major leadership changes at Novo Nordisk, Kenvue’s request for the FDA to ...
Perimenopausal women who used estrogen for at least 10 years before their periods stopped had 60% lower odds for breast ...
Kenvue, the maker of Tylenol, is urging U.S. health regulators not to add an autism warning label to it and other ...
“For over a decade — and as recently as August — FDA has fully evaluated the emerging scientific evidence and repeatedly ...
Kenvue, the maker of Tylenol, opposes proposed changes to the product's safety label regarding potential links to autism and ...
Tylenol's maker, Kenvue, has strongly opposed a proposed change to the product's safety label, following research suggesting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results